Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
02 2021
Historique:
received: 20 04 2020
revised: 26 06 2020
accepted: 21 09 2020
pubmed: 8 10 2020
medline: 15 5 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

To evaluate the cumulative prevalence of coeliac disease, systemic lupus erythematosus, autoimmune hyperthyroidism and primary immunodeficiencies in children with either newly diagnosed/persistent or chronic immune thrombocytopenia (ITP). Monocentric retrospective analysis of the clinical and biochemical features of 330 consecutive patients with ITP referred to our Pediatric Hematology Unit between January 2009 and December 2018. The prevalence of systemic lupus erythematosus (0.3%), coeliac disease (0.3%) and autoimmune hyperthyroidism (0.6%) was not increased compared to general paediatric population. Of note, the prevalence of underlying primary immunodeficiencies was 2.4%, remarkably higher than the general paediatric population (P = .005). All the patients diagnosed with immunodeficiency developed either bi-/trilinear cytopenia or splenomegaly. Whilst autoimmune and immunological screening is already recommended at the onset of immune thrombocytopenia, we recommend that primary immunodeficiencies be regularly screened during follow-up, especially in case of additional cytopenia or lymphoproliferation.

Identifiants

pubmed: 33025591
doi: 10.1111/apa.15593
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-651

Informations de copyright

©2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3:3780-3817.
Kühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the intercontinental cooperative immune thrombocytopenia study group. Haematologica. 2011;96:1831-1837.
Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther. 2015;32:875-887.
Sezgin Evim M, Baytan B, Güneş AM. Childhood immune thrombocytopenia: long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura. Turkish J Hematol. 2014;31:32-39.
Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47:657-659.
Ioachimescu AG, Makdissi A, Lichtin A, Zimmerman RS. Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid. 2007;17:1137-1142.
Zimmerman SA, Ware RE. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol. 1997;19:297-303.
Bay A, Coskun E, Leblebisatan G, et al. Prevalence and clinical significance of antithyroid antibodies in children with immune thrombocytopenic purpura. Pediatr Hematol Oncol. 2013;30:698-704.
Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57-62.
Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine. 2004;83:254-263.
Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16(1):61-64.
Pituch-Noworolska A, Siedlar M, Kowalczyk D, Szaflarska A, Błaut-Szlósarczyk A, Zwonarz K. Thrombocytopenia in common variable immunodeficiency patients - Clinical course, management, and effect of immunoglobulins. Cent Eur J Immunol. 2015;40(1):83-90.
Asghar R, Asghar A, Kasra M, et al. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008;7(3):169-175.
Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-186.
Tyler C, Edman JC. Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span. Prim Care. 2004;31:627-648.
Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:G1-G70.
De Mattia D, Del Principe D, Del Vecchio D, Jankovic M, Arrighini A, Giordano P. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Haematologica. 2000;85:420-424.
Associazione Italiana Ematologia Oncologia Pediatrica. Raccomandazioni per la gestione della trombocitopenia immune (ITP) persistente-cronica in età pediatrica. http://www.aieop.org/web/wp-content/uploads/2018/03/LG-ITP-cronica-18.10.17-1.pdf. Accessed April 15, 2020.
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an International Working Group. Blood. 2009;113(11):2386-2393.
Husby ÃS, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease. JPGN [Internet]. 2012;54:136-160.
Ross DS, Burch HB, Cooper DS, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343-1421.
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400-1412.
ESID Registry Working Party. ESID Registry - Working definitions for clinical diagnosis of IEI. 2019;1-33. https://esid.org/content/download/16792/456144/file/ESIDRegistry_ClinicalCriteria.pdf. Accessed April 15, 2020.
Bousfiha A, Jeddane L, Picard C, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38:129-143.
Rahman A, Isenberg DA. Systemic lupus erythematosus. New Engl J Med. 2008;358:929-939.
Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480-1493.
Brent GA. Graves' disease. N Engl J Med. 2008;358:2594-2605.
Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014;34:954-961.
Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.
Heitink-Polle KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood. 2014;124:3295-3307.
Giordano P, Delvecchio M, Lassandro G, et al. Can anti-thyroid antibodies influence the outcome of primary chronic immune thrombocytopenia in children? Endocr Metab Immune Disord Drug Targets. 2020;20(3):351-355.
Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170:1008-1019.
Giordano P, Urbano F, Lassandro G, et al. Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia. Pediatr Blood Cancer. 2019;66(1):e27452.
Aversa T, Lombardo F, Valenzise M, et al. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview. Ital. J Pediatr. 2015;41:39. Published 2015 May 15
Sarbay H. Investigation of celiac disease in patients followed by immun thrombocytopenic purpura diagnosis and comparison with literature. North Clin Istanbul. 2017;4:160.
Sarbay H, Cosan Sarbay B, Akın M, Kocamaz H, Tosun MS. Celiac disease presenting with immune thrombocytopenic Purpura. Case Rep Hematol. 2017;2017:1-3.
Bibbò S, Fozza C, Pes GM, Rojas R, Manetti R, Pina DM. Increased frequency of immune thrombocytopenic Purpura in Coeliac Disease and vice versa: a prospective observational study. Gastroenterol Res Pract. 2018;2018:2-6.
Notarangelo LD. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology. 2009;2009:139-143.
Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014;124(15):2337-2344.

Auteurs

Francesco Saettini (F)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Alessandro Cattoni (A)

Department of Pediatrics, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Martina Redaelli (M)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Daniela Silvestri (D)

Department of Pediatrics, San Gerardo Hospital, Fondazione Tettamanti, Università degli Studi di Milano-Bicocca, Monza, Italy.

Giulia Maria Ferrari (GM)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Andrea Biondi (A)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.
Department of Pediatrics, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Momcilo Jankovic (M)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Marco Spinelli (M)

Department of Pediatric Onco-Hematology, San Gerardo Hospital, Fondazione MBBM, Università degli Studi di Milano-Bicocca, Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH